B
BioBoss
Erik van den Berg: CEO of Memo Therapeutics
Episode 84
0:00-30:59
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Publisher
BioBoss
Link
wyantsimboli.com/bioboss/erik-van-den-berg-ceo-of-memo-therapeutics
Published
October 27, 2025
Duration
31 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
John Simboli
B
BioBoss
@bioboss
#erikvanden #memotherapeutics #lifesciences #investing
